Legend Biotech Corporation
LEGN
$27.75
$1.063.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 908.63M | 796.24M | 725.29M | 620.98M | 514.11M |
| Total Other Revenue | 335.00K | 598.00K | 3.02M | 6.26M | 6.07M |
| Total Revenue | 908.96M | 796.84M | 728.30M | 627.24M | 520.18M |
| Cost of Revenue | 776.37M | 698.91M | 665.69M | 648.13M | 607.90M |
| Gross Profit | 132.59M | 97.93M | 62.61M | -20.88M | -87.72M |
| SG&A Expenses | 323.53M | 315.77M | 300.54M | 284.26M | 263.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.10B | 1.01B | 966.23M | 932.39M | 871.43M |
| Operating Income | -190.94M | -217.84M | -237.93M | -305.15M | -351.24M |
| Income Before Tax | -222.49M | -304.30M | -197.48M | -158.13M | -345.46M |
| Income Tax Expenses | 17.21M | 21.03M | 20.67M | 18.89M | 2.67M |
| Earnings from Continuing Operations | -239.70 | -325.33 | -218.15 | -177.03 | -348.13 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -239.70M | -325.33M | -218.15M | -177.03M | -348.13M |
| EBIT | -190.94M | -217.84M | -237.93M | -305.15M | -351.24M |
| EBITDA | -181.32M | -209.01M | -228.34M | -294.29M | -340.53M |
| EPS Basic | -2.60 | -3.54 | -2.38 | -1.94 | -3.82 |
| Normalized Basic EPS | -0.74 | -1.02 | -0.65 | -0.53 | -1.18 |
| EPS Diluted | -2.61 | -3.54 | -2.38 | -1.94 | -3.82 |
| Normalized Diluted EPS | -0.75 | -1.03 | -0.67 | -0.54 | -1.18 |
| Average Basic Shares Outstanding | 735.86M | 734.50M | 732.97M | 731.21M | 729.72M |
| Average Diluted Shares Outstanding | 376.97M | 376.29M | 375.52M | 374.65M | 364.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |